APO RESEARCH · REPORT
Molecular Microbiology
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Product & engineering
Understand the product.
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Selected research
Industry Research
Molecular Microbiology Industry Research Report 2026
Market perspective
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology. In this report, we study global trends in the usage and purchase of diagnostic kits for the quantitative PCR detection and identification of pathogenic microorganisms using molecular microbiology (DNA/RNA diagnostics), both in human and veterinary medicine.
Global Molecular Microbiology key players include Roche, Qiagen, Illumina, Abbott, BioMerieux, etc. Global top five manufacturers hold a share about 65%. North America is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Quantitative PCR Detection Diagnostic Kits is the largest segment, with a share about 45%. And in terms of application, the largest application is Human, followed by Veterinary.
Report Scope
Read the full market overview
This report quantifies the global Molecular Microbiology market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Microbiology Market by Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Molecular Microbiology Segment by Type
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits
Other
Molecular Microbiology Segment by Application
Human
Veterinary
Molecular Microbiology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Microbiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Microbiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Microbiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Molecular Microbiology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Molecular Microbiology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Molecular Microbiology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Quantitative PCR Detection Diagnostic Kits
- Pathogenic Microorganisms Diagnostic Kits
- Other
Applications
- Human
- Veterinary
Companies covered
- Roche
- Qiagen
- Illumina
- Abbott
- Hologic
- BioMerieux
- Danaher (Cepheid)
- Myriad Genetics
- DAAN Gene
- Agilent
- Genomic Health
- BD
- Foundation Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Molecular Microbiology Market Size (2021-2032)
- 2.2.2 Global Molecular Microbiology Sales (2021-2032)
- 2.2.3 Global Molecular Microbiology Market Average Price (2021-2032)
- 2.3 Molecular Microbiology by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Quantitative PCR Detection Diagnostic Kits
- 2.3.3 Pathogenic Microorganisms Diagnostic Kits
- 2.3.4 Other
- 2.4 Molecular Microbiology by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Veterinary
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Molecular Microbiology Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Molecular Microbiology Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Molecular Microbiology Revenue of Manufacturers (2021-2026)
- 3.4 Global Molecular Microbiology Average Price by Manufacturers (2021-2026)
- 3.5 Global Molecular Microbiology Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Molecular Microbiology, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Molecular Microbiology, Product Type & Application
- 3.8 Global Manufacturers of Molecular Microbiology, Established Date
- 3.9 Global Molecular Microbiology Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Molecular Microbiology Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Qiagen
- 4.2.1 Qiagen Company Information
- 4.2.2 Qiagen Business Overview
- 4.2.3 Qiagen Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qiagen Molecular Microbiology Product Portfolio
- 4.2.5 Qiagen Recent Developments
- 4.3 Illumina
- 4.3.1 Illumina Company Information
- 4.3.2 Illumina Business Overview
- 4.3.3 Illumina Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Illumina Molecular Microbiology Product Portfolio
- 4.3.5 Illumina Recent Developments
- 4.4 Abbott
- 4.4.1 Abbott Company Information
- 4.4.2 Abbott Business Overview
- 4.4.3 Abbott Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Abbott Molecular Microbiology Product Portfolio
- 4.4.5 Abbott Recent Developments
- 4.5 Hologic
- 4.5.1 Hologic Company Information
- 4.5.2 Hologic Business Overview
- 4.5.3 Hologic Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hologic Molecular Microbiology Product Portfolio
- 4.5.5 Hologic Recent Developments
- 4.6 BioMerieux
- 4.6.1 BioMerieux Company Information
- 4.6.2 BioMerieux Business Overview
- 4.6.3 BioMerieux Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioMerieux Molecular Microbiology Product Portfolio
- 4.6.5 BioMerieux Recent Developments
- 4.7 Danaher (Cepheid)
- 4.7.1 Danaher (Cepheid) Company Information
- 4.7.2 Danaher (Cepheid) Business Overview
- 4.7.3 Danaher (Cepheid) Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Danaher (Cepheid) Molecular Microbiology Product Portfolio
- 4.7.5 Danaher (Cepheid) Recent Developments
- 4.8 Myriad Genetics
- 4.8.1 Myriad Genetics Company Information
- 4.8.2 Myriad Genetics Business Overview
- 4.8.3 Myriad Genetics Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Myriad Genetics Molecular Microbiology Product Portfolio
- 4.8.5 Myriad Genetics Recent Developments
- 4.9 DAAN Gene
- 4.9.1 DAAN Gene Company Information
- 4.9.2 DAAN Gene Business Overview
- 4.9.3 DAAN Gene Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DAAN Gene Molecular Microbiology Product Portfolio
- 4.9.5 DAAN Gene Recent Developments
- 4.10 Agilent
- 4.10.1 Agilent Company Information
- 4.10.2 Agilent Business Overview
- 4.10.3 Agilent Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Agilent Molecular Microbiology Product Portfolio
- 4.10.5 Agilent Recent Developments
- 4.11 Genomic Health
- 4.11.1 Genomic Health Company Information
- 4.11.2 Genomic Health Business Overview
- 4.11.3 Genomic Health Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Genomic Health Molecular Microbiology Product Portfolio
- 4.11.5 Genomic Health Recent Developments
- 4.12 BD
- 4.12.1 BD Company Information
- 4.12.2 BD Business Overview
- 4.12.3 BD Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BD Molecular Microbiology Product Portfolio
- 4.12.5 BD Recent Developments
- 4.13 Foundation Medicine
- 4.13.1 Foundation Medicine Company Information
- 4.13.2 Foundation Medicine Business Overview
- 4.13.3 Foundation Medicine Molecular Microbiology Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Foundation Medicine Molecular Microbiology Product Portfolio
- 4.13.5 Foundation Medicine Recent Developments
5 Global Molecular Microbiology Market Scenario by Region
- 5.1 Global Molecular Microbiology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Molecular Microbiology Sales by Region: 2021-2032
- 5.2.1 Global Molecular Microbiology Sales by Region: 2021-2026
- 5.2.2 Global Molecular Microbiology Sales by Region: 2027-2032
- 5.3 Global Molecular Microbiology Revenue by Region: 2021-2032
- 5.3.1 Global Molecular Microbiology Revenue by Region: 2021-2026
- 5.3.2 Global Molecular Microbiology Revenue by Region: 2027-2032
- 5.4 North America Molecular Microbiology Market Facts & Figures by Country
- 5.4.1 North America Molecular Microbiology Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Molecular Microbiology Sales by Country (2021-2032)
- 5.4.3 North America Molecular Microbiology Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Molecular Microbiology Market Facts & Figures by Country
- 5.5.1 Europe Molecular Microbiology Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Molecular Microbiology Sales by Country (2021-2032)
- 5.5.3 Europe Molecular Microbiology Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Molecular Microbiology Market Facts & Figures by Country
- 5.6.1 Asia Pacific Molecular Microbiology Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Molecular Microbiology Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Molecular Microbiology Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Molecular Microbiology Market Facts & Figures by Country
- 5.7.1 South America Molecular Microbiology Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Molecular Microbiology Sales by Country (2021-2032)
- 5.7.3 South America Molecular Microbiology Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Molecular Microbiology Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Molecular Microbiology Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Molecular Microbiology Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Molecular Microbiology Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Molecular Microbiology Sales by Type (2021-2032)
- 6.1.1 Global Molecular Microbiology Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Molecular Microbiology Sales Market Share by Type (2021-2032)
- 6.2 Global Molecular Microbiology Revenue by Type (2021-2032)
- 6.2.1 Global Molecular Microbiology Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Molecular Microbiology Revenue Market Share by Type (2021-2032)
- 6.3 Global Molecular Microbiology Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Molecular Microbiology Sales by Application (2021-2032)
- 7.1.1 Global Molecular Microbiology Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Molecular Microbiology Sales Market Share by Application (2021-2032)
- 7.2 Global Molecular Microbiology Revenue by Application (2021-2032)
- 7.2.1 Global Molecular Microbiology Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Molecular Microbiology Revenue Market Share by Application (2021-2032)
- 7.3 Global Molecular Microbiology Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Molecular Microbiology Value Chain Analysis
- 8.1.1 Molecular Microbiology Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Molecular Microbiology Production Mode & Process
- 8.2 Molecular Microbiology Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Molecular Microbiology Distributors
- 8.2.3 Molecular Microbiology Customers
9 Global Molecular Microbiology Analyzing Market Dynamics
- 9.1 Molecular Microbiology Industry Trends
- 9.2 Molecular Microbiology Industry Drivers
- 9.3 Molecular Microbiology Industry Opportunities and Challenges
- 9.4 Molecular Microbiology Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst